Rinvoq ER 45 MG tablet UU 28S
Ended Awarded
- Contract number
- SPE2DB25FAVZS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,164
Award facts
- Contract value 100% obligated
- $18,163.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,163.51 to DMS Pharmaceutical Group Inc. on August 12, 2025, for the supply of RINVOQ ER 45 mg tablets (28-count units). This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a specific product fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. No set-aside designation was used for this award. The place of performance is listed as Conshohocken, Pennsylvania.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, holds a significant single-award IDC with the DLA valued at $499,999,999 and valid through November 2026. This broader contract vehicle enables the DLA to issue firm fixed-price delivery orders for comprehensive pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide. The company has established itself as a critical supplier in the federal pharmaceutical supply chain, with a robust portfolio of contract awards covering prescription medications, biologics, vaccines, and specialized pharmaceutical products distributed to military health facilities across the nation.
Quick answers
Who was awarded contract SPE2DB25FAVZS?
SPE2DB25FAVZS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FAVZS worth?
The government has obligated $18,164 on SPE2DB25FAVZS.
Is contract SPE2DB25FAVZS an order under another contract?
Yes. SPE2DB25FAVZS is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAVZS competed?
The extent of competition for SPE2DB25FAVZS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award